Ask AI
ProCE Banner Activity

CE

EngageTD: Workshop-Based Training in Tardive Dyskinesia Evaluation and Personalized Care

Video

As use of dopamine receptor–blocking agents expands for the treatment of multiple psychiatric conditions, many patients are at risk of developing tardive dyskinesia. Older patients are often at increased risk because of their potentially prolonged exposure, particularly to first-generation antipsychotics. Learn best practices for screening and discussing symptoms with patients in this on-demand webcast tailored toward advanced practice mental health providers.

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Nurse Practitioners/Nurses: 1.50 Nursing contact hours, including 1.50 hours of pharmacotherapy credit

Released: July 28, 2026

Expiration: July 27, 2027

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Teva.

Teva

Target Audience

This activity is intended for nurse practitioners, nurses, physician associates, and others involved in the care of patients with tardive dyskinesia who may benefit from this education.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Tardive Dyskinesia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement proactive risk-stratification and monitoring strategies to identify and counsel older adults or long-term antipsychotic-treated patients at heightened risk for TD

  • Apply validated screening tools and structured assessment protocols within routine clinical workflows to ensure timely detection, documentation, and follow-up of TD across diverse care settings

  • Evaluate the efficacy, safety, and tolerability profiles of FDA-approved VMAT2 inhibitors to individualize pharmacologic management of TD in older adults and special populations

Financial Disclosures

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Eric Carlon, APRN, PMHNP-BC: consultant/advisor/speaker: Teva.

Jeremy Schreiber, MSN, APRN, PMHNP-BC: consultant/advisor/speaker: Alkermes, Axsome, Biogen, Bristol Myers Squibb, Intra-Cellular, Janssen, Johnson & Johnson, Neurocrine, Sage, Supernus, Teva, Vanda; individual publicly traded stocks/stock options: Biogen, Bristol Myers Squibb, Sage.

The planners, moderator, and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose, except Jayson Gesulga, PA-C, MMS, CAQ-Psychiatry,  as noted below:

Jayson Gesulga, PA-C, MMS, CAQ-Psychiatry: consultant/advisor/speaker: AbbVie, Alkermes, Axsome, Bristol Myers Squibb, Johnson & Johnson, Neurocrine, Otsuka, Teva.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 28, 2026, through July 27, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Additional Disclosures

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours, including 1.5 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education 

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until July 27, 2027. PAs should only claim credit commensurate with the extent of their participation.